Neurologic clinical trial -ALXN1720-MG-301

Neurologic

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05556096

Neurologic clinical trial -ALXN1720-MG-301

Drug

ALXN1720

Phase

Phase III

Condition

Generalized Myasthenia Gravis

Keywords

MG | Generalized Myasthenia Gravis | CMG